Rifabutin versus rifampicin for treatment of staphylococcal prosthetic joint infection treated with debridement, antibiotics and implant retention (DAIR strategy): a multicenter randomized, open-label, non-inferiority trial
Latest Information Update: 01 Jul 2021
At a glance
- Drugs Rifabutin (Primary) ; Rifampicin
- Indications Staphylococcal infections
- Focus Therapeutic Use
- Acronyms RIFAMAB
- 18 Dec 2020 New trial record